advertisement
Ironwood Pharma initiated with "buy"
09/08/10 - Ladenburg Thalmann
NEW YORK, September 8 (newratings.com) - Analysts at Ladenburg Thalmann initiate coverage of Ironwood Pharma (IRWD) with a "buy" rating. The target price is set to $14.
News